Darrell A. Henze

Pain & Migraine Research Merck Research Laboratories, Boston, MA, United States 
Neuroscience, Pain, TrkA, cannabinoids, sodium channels
"Darrell Henze"
Mean distance: 13.66 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kraus RL, Zhao F, Pall PS, et al. (2021) Na1.7 target modulation and efficacy can be measured in nonhuman primate assays. Science Translational Medicine. 13
Ballard JE, Pall P, Vardigan J, et al. (2020) Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate. Pharmaceutical Research. 37: 181
Grauer SM, Sanoja R, Poulin D, et al. (2020) Antinociceptive Effects of Potent, Selective and Brain Penetrant Muscarinic M Positive Allosteric Modulators in Rodent Pain Models. Brain Research. 146814
Vardigan JD, Houghton AK, Lange HS, et al. (2018) Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects. Journal of Pain Research. 11: 735-741
Pero JE, Rossi MA, Lehman HDGF, et al. (2017) Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model. Bioorganic & Medicinal Chemistry Letters
Hurzy DM, Henze DA, Cabalu TD, et al. (2017) Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors. Bioorganic & Medicinal Chemistry Letters
Price EA, Krasowska-Zoladek A, Nanda KK, et al. (2017) Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathway. Journal of Neuroscience Methods
Su HP, Rickert K, Burlein C, et al. (2016) Structural characterization of nonactive site, TrkA-selective kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America
Solly K, Klein R, Rudd M, et al. (2015) High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays. Journal of Biomolecular Screening. 20: 708-19
Stachel SJ, Sanders JM, Henze DA, et al. (2014) Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain. Journal of Medicinal Chemistry. 57: 5800-16
See more...